Quest Diagnostics (DGX) Tops Q2 EPS by 5c; offers guidance
Tweet
Share
E-mail
Get Alerts DGX Hot Sheet
Price: $237.14 --0%
EPS Growth %: +10.0%
Financial Fact:
Dividends per common share: 0.4
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +10.0%
Financial Fact:
Dividends per common share: 0.4
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Quest Diagnostics (NYSE: DGX) reported Q2 EPS of $2.62, $0.05 better than the analyst estimate of $2.57. Revenue for the quarter came in at $2.76 billion versus the consensus estimate of $2.73 billion.
GUIDANCE:
Quest Diagnostics sees FY2025 EPS of $9.63-$9.83, versus the consensus of $9.70. Quest Diagnostics sees FY2025 revenue of $10.8-10.92 billion, versus the consensus of $10.795 billion.
For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi turns more bullish on trucking stocks
- Google Cloud, Accenture Launch Unit to Put AI Engineers On-Site With Customers - WSJ
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
